AMGEN INC

NASDAQ: AMGN (Amgen Inc.)

Kemas kini terakhir: 4 hari lalu, 4:12PM

291.81

-1.62 (-0.55%)

  • 1H -0.55%
  • 5H 1.67%
  • 1B 7.12%
  • 6B 9.50%
  • Tahun Ke Tarikh 12.55%
  • 1T -3.78%
  • 5T 28.62%
Penutupan Terdahulu 293.43
Buka 293.21
Jumlah Dagangan 1,709,970
Purata Dagangan (3B) 3,010,806
Modal Pasaran 156,907,978,752
Harga / Pendapatan (P/E TTM) 26.31
Harga / Pendapatan (P/E Ke hadapan) 13.93
Harga / Jualan (P/S) 4.61
Harga / Buku (P/B) 25.15
Julat 52 Minggu
253.30 (-13%) — 346.85 (18%)
Tarikh Pendapatan 4 Aug 2025 - 8 Aug 2025
Hasil Dividen (DY TTM) 3.17%
Margin Keuntungan 17.39%
Margin Operasi (TTM) 28.73%
EPS Cair (TTM) 10.97
Pertumbuhan Hasil Suku Tahunan (YOY) 9.40%
Pertumbuhan Pendapatan Suku Tahunan (YOY) -18.30%
Jumlah Hutang/Ekuiti (D/E MRQ) 924.46%
Nisbah Semasa (MRQ) 1.17
Aliran Tunai Operasi (OCF TTM) 12.19 B
Aliran Tunai Bebas Leveraj (LFCF TTM) 13.09 B
Pulangan Atas Aset (ROA TTM) 7.04%
Pulangan Atas Ekuiti (ROE TTM) 105.67%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Drug Manufacturers - General (US) Menurun Bercampur
Drug Manufacturers - General (Global) Menurun Bercampur
Stok Amgen Inc. Menaik Menurun

AISkor Stockmoo

0.8
Konsensus Penganalisis 1.5
Aktiviti Orang Dalam NA
Volatiliti Harga 2.0
Purata Bergerak Teknikal -2.5
Osilator Teknikal 2.0
Purata 0.75

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
AMGN 157 B 3.17% 26.31 25.15
GILD 124 B 3.13% 20.97 7.30
AZN 226 B 2.13% 29.27 6.19
SNY 122 B 4.43% 17.53 1.46
GRFS 6 B - 28.00 0.910
BIIB 17 B - 11.68 1.14

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Sektor Healthcare
Industri Drug Manufacturers - General
Gaya Pelaburan Large Value
% Dimiliki oleh Orang Dalam 0.22%
% Dimiliki oleh Institusi 83.66%
345.10345.10311.80311.80278.50278.50245.20245.20211.90211.90Harga Sasaran MedianQ2 '20Q2 '20Q3 '20Q3 '20Q4 '20Q4 '20Q1 '21Q1 '21Q2 '21Q2 '21Q3 '21Q3 '21Q4 '21Q4 '21Q1 '22Q1 '22Q2 '22Q2 '22Q3 '22Q3 '22Q4 '22Q4 '22Q1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25
Julat 52 Minggu
253.30 (-13%) — 346.85 (18%)
Julat Harga Sasaran
280.00 (-4%) — 330.00 (13%)
Tinggi 330.00 (Morgan Stanley, 13.09%) Pegang
Median 317.50 (8.80%)
Rendah 280.00 (Mizuho, -4.05%) Pegang
Purata 310.17 (6.29%)
Jumlah 2 Beli, 4 Pegang
Harga Purata @ Panggilan 279.47
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Guggenheim 20 May 2025 288.00 (-1.31%) Pegang 275.01
Piper Sandler 16 May 2025 328.00 (12.40%) Beli 272.41
Mizuho 07 May 2025 280.00 (-4.05%) Pegang 275.84
RBC Capital 02 May 2025 320.00 (9.66%) Beli 281.22
UBS 02 May 2025 315.00 (7.95%) Pegang 281.22
14 Apr 2025 319.00 (9.32%) Pegang 293.92
Morgan Stanley 09 Apr 2025 330.00 (13.09%) Pegang 291.09

Tiada data dalam julat masa ini.

  • 3M
Tarikh Jenis Butiran
13 Jun 2025 Pengumuman AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY
05 Jun 2025 Pengumuman AMGEN TO PRESENT AT GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
05 Jun 2025 Pengumuman BetterInvesting™ Magazine Update on The Walt Disney Co. (NYSE: DIS)
02 Jun 2025 Pengumuman IMDELLTRA® SIGNIFICANTLY REDUCED RISK OF DEATH BY 40% IN SMALL CELL LUNG CANCER PATIENTS
30 May 2025 Pengumuman AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
27 May 2025 Pengumuman BetterInvesting™ Magazine Update on Stride Inc. (NYSE: LRN) and Amgen Inc. (NASDAQ: AMGN)
16 May 2025 Pengumuman AMGEN TO PRESENT AT THE 2025 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
12 May 2025 CNBC Trump's plan to slash drug prices may struggle to get off the ground – here's what to know 
09 May 2025 Pengumuman AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
01 May 2025 Pengumuman AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
28 Apr 2025 Pengumuman AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS
25 Apr 2025 Pengumuman AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO
24 Apr 2025 CNBC Corporate America shelled out millions for Trump's inauguration. Now he's upending many of their businesses
11 Apr 2025 Pengumuman IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER
09 Apr 2025 CNBC Pharmaceutical stocks rise as Trump pauses tariffs but not for China
03 Apr 2025 Pengumuman UPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE
Papar semua
Hasil Dividen (DY TTM) 3.17%
Purata Hasil Dividen 5T 3.06%
Nisbah Pembayaran 83.23%
Jangkaan Pembayaran Dividen Seterusnya Sep 2025
Tarikh EX Tarikh Pengumuman Tarikh Pembayaran Perincian
16 May 2025 04 Mar 2025 06 Jun 2025 2.38 Tunai
14 Feb 2025 10 Dec 2024 07 Mar 2025 2.38 Tunai
18 Nov 2024 25 Oct 2024 09 Dec 2024 2.25 Tunai
16 Aug 2024 02 Aug 2024 06 Sep 2024 2.25 Tunai
16 May 2024 06 Mar 2024 07 Jun 2024 2.25 Tunai
15 Feb 2024 12 Dec 2023 07 Mar 2024 2.25 Tunai
16 Nov 2023 24 Oct 2023 08 Dec 2023 2.13 Tunai
17 Aug 2023 01 Aug 2023 08 Sep 2023 2.13 Tunai
17 May 2023 07 Mar 2023 08 Jun 2023 2.13 Tunai
14 Feb 2023 12 Dec 2022 08 Mar 2023 2.13 Tunai
16 Nov 2022 28 Oct 2022 08 Dec 2022 1.94 Tunai
17 Aug 2022 03 Aug 2022 08 Sep 2022 1.94 Tunai
16 May 2022 02 Mar 2022 08 Jun 2022 1.94 Tunai
14 Feb 2022 03 Dec 2021 08 Mar 2022 1.94 Tunai
15 Nov 2021 21 Oct 2021 08 Dec 2021 1.76 Tunai
16 Aug 2021 30 Jul 2021 08 Sep 2021 1.76 Tunai
14 May 2021 03 Mar 2021 08 Jun 2021 1.76 Tunai
11 Feb 2021 16 Dec 2020 08 Mar 2021 1.76 Tunai
13 Nov 2020 21 Oct 2020 08 Dec 2020 1.6 Tunai
14 Aug 2020 23 Jul 2020 08 Sep 2020 1.6 Tunai
15 May 2020 04 Mar 2020 08 Jun 2020 1.6 Tunai
13 Feb 2020 11 Dec 2019 06 Mar 2020 1.6 Tunai
14 Nov 2019 22 Oct 2019 06 Dec 2019 1.45 Tunai
14 Aug 2019 02 Aug 2019 06 Sep 2019 1.45 Tunai
16 May 2019 07 Mar 2019 07 Jun 2019 1.45 Tunai
14 Feb 2019 07 Dec 2018 08 Mar 2019 1.45 Tunai
15 Nov 2018 23 Oct 2018 07 Dec 2018 1.32 Tunai
16 Aug 2018 31 Jul 2018 07 Sep 2018 1.32 Tunai
16 May 2018 07 Mar 2018 08 Jun 2018 1.32 Tunai
14 Feb 2018 12 Dec 2017 08 Mar 2018 1.32 Tunai
16 Nov 2017 24 Oct 2017 08 Dec 2017 1.15 Tunai
15 Aug 2017 28 Jul 2017 08 Sep 2017 1.15 Tunai
15 May 2017 07 Mar 2017 08 Jun 2017 1.15 Tunai
13 Feb 2017 20 Dec 2016 08 Mar 2017 1.15 Tunai
14 Nov 2016 14 Oct 2016 08 Dec 2016 1 Tunai
15 Aug 2016 22 Jul 2016 08 Sep 2016 1 Tunai
13 May 2016 02 Mar 2016 08 Jun 2016 1 Tunai
11 Feb 2016 15 Dec 2015 08 Mar 2016 1 Tunai
12 Nov 2015 14 Oct 2015 07 Dec 2015 0.79 Tunai
13 Aug 2015 28 Jul 2015 08 Sep 2015 0.79 Tunai
12 May 2015 04 Mar 2015 05 Jun 2015 0.79 Tunai
10 Feb 2015 17 Dec 2014 06 Mar 2015 0.79 Tunai
10 Nov 2014 17 Oct 2014 05 Dec 2014 0.61 Tunai
12 Aug 2014 25 Jul 2014 05 Sep 2014 0.61 Tunai
13 May 2014 05 Mar 2014 06 Jun 2014 0.61 Tunai
11 Feb 2014 13 Dec 2013 07 Mar 2014 0.61 Tunai
12 Nov 2013 16 Oct 2013 06 Dec 2013 0.47 Tunai
14 Aug 2013 26 Jul 2013 06 Sep 2013 0.47 Tunai
14 May 2013 06 Mar 2013 07 Jun 2013 0.47 Tunai
11 Feb 2013 13 Dec 2012 07 Mar 2013 0.47 Tunai
Papar semua

Hasil Dividen Tahunan

Tahun Dividen Tahunan ($) Kekerapan/Tahun Hasil %
2025 4.76 2 1.63
2024 9.00 4 3.45
2023 8.52 4 2.96
2022 7.76 4 2.96
2021 7.04 4 3.13
2020 6.40 4 2.78
2019 5.80 4 2.41
2018 5.28 4 2.71
2017 4.60 4 2.65
2016 4.00 4 2.74
2015 3.16 4 1.95
2014 2.44 4 1.53
2013 1.88 4 1.65
Papar semua
297.31297.31290.62290.62283.94283.94277.25277.25270.56270.56Jun 2Jun 2Jun 3Jun 3Jun 4Jun 4Jun 5Jun 5Jun 6Jun 6Jun 9Jun 9Jun 10Jun 10Jun 11Jun 11

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
6.0006.0004.0004.0002.0002.0000.0000.000-2.000-2.000MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda